¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"lymphocyte transfusion"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
sensitized lymphocyte
¹Î°¨È¸²ÇÁ±¸
autologous transfusion
ÀÚ°¡¼öÇ÷
acute hemolytic transfusion reaction
±Þ¼º¿ëÇ÷¼º¼öÇ÷¹ÝÀÀ
blood transfusion reaction
¼öÇ÷¹ÝÀÀ
component transfusion
¼ººÐ¼öÇ÷
cryoprecipitate transfusion
µ¿°áħÀüÁ¦Á¦¼öÇ÷
delayed hemolytic transfusion reaction
Áö¿¬¿ëÇ÷¼º¼öÇ÷¹ÝÀÀ
direct transfusion
Á÷Á¢¼öÇ÷
exchange transfusion
±³È¯¼öÇ÷
febrile transfusion reaction
¹ß¿¼º¼öÇ÷¹ÝÀÀ
fetomaternal transfusion
žƸðü¼öÇ÷
fetus to fetus transfusion
žƻçÀ̼öÇ÷
hemolytic transfusion reaction
¿ëÇ÷¼º¼öÇ÷¹ÝÀÀ
immediate transfusion
Áï½Ã¼öÇ÷, ¹Ù·Î¼öÇ÷
incompatible blood transfusion
ºÎÀûÇÕ¼öÇ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
thymus-derived lymphocyte
°¡½¿»ùÀ¯·¡¸²ÇÁ±¸
mixed lymphocyte reaction
¸²ÇÁ±¸È¥ÇÕ¹è¾ç¹ÝÀÀ
mixed lymphocyte culture test
È¥ÇÕ¸²ÇÁ±¸¹è¾ç°Ë»ç
monocyte lymphocyte ratio
´ÜÇÙ±¸¸²ÇÁ±¸ºñÀ²
primed lymphocyte typing
ÃÊȸÇ׿øÀÚ±ØÈĸ²ÇÁ±¸Çüº°È
primed lymphocyte-typing test
°¨ÀÛ¸²ÇÁ±¸Çüº°°Ë»ç
acute hemolytic transfusion reaction
±Þ¼º¿ëÇ÷¼öÇ÷¹ÝÀÀ
autologous transfusion
(¢¡autotransfusion) ÀÚ°¡¼öÇ÷
blood transfusion reaction
¼öÇ÷¹ÝÀÀ
bone marrow transfusion
°ñ¼ö¼öÇ÷
component transfusion
¼ººÐ¼öÇ÷
cryoprecipitate transfusion
µ¿°áħÀüÁ¦Á¦¼öÇ÷
delayed hemolytic transfusion reaction
Áö¿¬¿ëÇ÷¼öÇ÷ºÎÀÛ¿ë
direct transfusion
(¢¡immediate transfusion) Áï½Ã¼öÇ÷, ¹Ù·Î¼öÇ÷
exchange transfusion
±³È¯¼öÇ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
pre-transfusion testing
¼öÇ÷Àü°Ë»ç
B cell/lymphocyte
B ¼¼Æ÷/¸²ÇÁ±¸
B lymphocyte
B ¸²ÇÁ±¸
B-lymphocyte
B ¸²ÇÁ±¸.
Bare lymphocyte syndrome
¹«Ç¥Áö¸²ÇÁ±¸ÁõÈıº
T cell/lymphocyte
T ¼¼Æ÷/¸²ÇÁ±¸
T lymphocyte
T ¸²ÇÁ±¸
T-lymphocyte
T-Àӯı¸
anti-lymphocyte globulin
¸²ÇÁ±¸ Çױ۷κҸ°
antigen, lymphocyte defined (LD)
¸²ÇÁ±¸ Ç¥¸éÇ׿ø, LDÇ׿ø
granulocyte-monocyte-lymphocyte antigens
°ú¸³±¸´Ü±¸¸²ÇÁ±¸Ç׿ø
granulocyte-platelet-lymphocyte antigens
°ú¸³±¸Ç÷¼ÒÆÇ¸²ÇÁ±¸Ç׿ø
hodgkins disease,lymphocyte predominance
¸²ÇÁ±¸ ÇöÀúÇü
primed lymphocyte
ÃÊȸ°¨ÀÛ ¸²ÇÁ±¸
primed lymphocyte typing
ÃÊȸÇ׿øÀÚ±ØÈÄ ¸²ÇÁ±¸Çüº°È
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
lymphocyte
¸²ÇÁ±¸
lymphocyte activating factor
¸²ÇÁ±¸È°¼ºÀÎÀÚ
lymphocyte activating factor (LAF)
¸²ÇÁ±¸ Ȱ¼ºÈÀÎÀÚ
lymphocyte analysis
¸²ÇÁ±¸ºÐ¼®
lymphocyte culture, mixed
È¥ÇÕ ¸²ÇÁ±¸¹è¾ç
lymphocyte defined antigen
¸²ÇÁ±¸±ÔÁ¤Ç׿ø.
lymphocyte development
¸²ÇÁ±¸¹ßÀ°
lymphocyte dysfunction
¸²ÇÁ±¸±â´ÉÀå¾Ö<--ºÎÀü>
lymphocyte inhibitory factor (LIF)
¸²ÇÁ±¸¾ïÁ¦ÀÎÀÚ
lymphocyte interaction
¸²ÇÁ±¸»óÈ£ÀÛ¿ë.
lymphocyte microcytotoxicity assay
¸²ÇÁ±¸¼Ò¼¼Æ÷µ¶¼º°Ë»ç
lymphocyte production
¸²ÇÁ±¸»ý¼º
lymphocyte proliferation
¸²ÇÁ±¸Áõ½Ä
lymphocyte transformation
¸²ÇÁ±¸Àüȯ(¡Ï¹ ï®üµ).
lymphocyte, resident
»óÁÖ¸²ÇÁ±¸
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½